Teleflex gains next-gen coating tech with $30m Semprus acquisition
This article was originally published in Clinica
Executive Summary
In a move that highlights its continuing ambition to expand in the medtech arena, Teleflex has acquired Semprus BioSciences, a developer of antimicrobial coating technology, for $30m upfront. Teleflex could also pay up to $50m in milestones, according to MassDevice.